What is cholesterol?
- a lipid (type of fat) plays essential physiological role in the body
Where does it come from?
- very little in food, eggs offal shellfish high
- saturated fat turned into cholesterol in liver
Why do we need cholesterol?
- without cholesterol the body won't work
- like specialised bricks it is needed for forming all cell membranes
- insulates nerve fibres, allowing chemical messages to travel
- synthesis hormones
Why is it bad?
- coronary artery disease
- disease of arteries
Need to know something about Lipoproteins - the molecules transport cholesterol
Cholesterol on it's own not good enough
- Low density lipoproteins (LDL-C) is BAD cholesterol
- High density lipoproteins (HDL-C) is GOOD cholesterol
- Triglycerides
Plaque formation
- Atherosclerosis starts with "fatty streaks" due to oxidised (LDL-C) BAD clinging to walls releasing extracellular cholesterol
Data
- Average Total Cholesterol level in UK --> 5.8 mmol/l
- Average Total Cholesterol Northumberland --> 6.5 mmol/l
- Healthy cholesterol range Total cholesterol less than 5.2 mmol/l
- LDL cholesterol less than 3.0 mmol/l
- HDL cholesterol more than 1.15mmol/l
British Hyperlipidaemia Society classifies level (Total Cholesterol)
- desirable (<5.2 mmol/I)
- borderline (5.2 -6.4 mmol/1)
- abnormal (6.5-7.8mmol/1)
- high (>7.8mmol/1)
Abnormal value - What should we do?
- order lipid profile
- total cholesterol (TOTAL-C), HDL-C level, Cholesterol / HDL-C ratio
|
Confused? So am I |
Primary prevention of CHD
Government decided only those with risk of CHD events greater than 30% over 10 years warrant treatment
So what should we be doing?
Secondary Prevention EASY --> all know what to do?
- total cholesterol below 5 mmol/l
Primary Prevention NOT so EASY - High cholesterol levels alone poor predictor CHD
- identify risk assessment
- total cholesterol > 5mmol/l
- Sheffield Tables
- Framingham Risk calculator
Generally Abnormal Values are:
- LDL cholesterol > 4 mmol/litre
- HDL cholesterol <1 mmol/litre
- Total cholesterol:HDL cholesterol >6.5 mmol/litre
National Service Framework (NSF) for Coronary Heart Disease (CHD)
- primary care to achieve goals coronary heart disease prevention
- including lipid modification
Cost of achieving CHD NSF lipid-lowering goals £31,000 to £52,000 per GP
Currently
- majority English adults have adverse lipid levels
- few people on lipid-lowering drugs as currently recommended
Secondary Prevention of CHD
This group most to gain from therapy
- smoking
- weight exercise
- blood pressure below 140/85
- low dose aspirin 75 mgs
- statins cholesterol less than 5mmol/l
- ACE inhibitors
- Beta blockers
- Warfarin / aspirin for atrial fibrillation
- diabetes glucose blood pressure
Currently
- only 2.5% adult population taking lipid lowering drugs (statins)
- rates low among high risk patients for primary prevention
- fewer than 4% individuals eligible for primary prevention receive statins
- less than 30% of established CHD are taking statins
- total target cholesterol levels are less than 50% in those on treatment
Key message
- implementing NSF standards then 8.4% population should be taking statins (age 35-64)
- number rise to 14% taking statins (age to 75)
2001Where are we now? Doing rather well
WE MUST IDENTIFY THE REMAINING 13% without a cholesterol measurement
WE MUST IDENTIFY THIS GROUP AND LOWER THIS LEVEL ACCORDING TO NSF FACTS AND FIGURES - GROAN
Therefore 142 of our NSF criteria patients still no cholesterol measurement
|
Benefits of Statins
How do they work
Biosynthesis precursors --- HMG-CoA reductase enzyme --> cholesterol
Statins act here
- demonstrated in 5 randomised placebo-controlled trials (30,000) 4S, WOSCOP, CARE etc.
- results suggest risk reduction 34% coronary events in primary prevention
30% coronary events in secondary prevention
- statin therapy taken for 5 years seems to reduce stroke by 25% too
So, which drug?
- current evidence suggests simvastatin first line prevention
Choice of statin to be used open for debate
Evidence-based medicine suggests simvastatin or pravastatin first choice per major clinical trials
Atorvastatin may be first choice for mixed hyperlipidaemia since reduced triglycerides
Examples
| Mrs Shirley S Age 67 years Clinical data: Hypertension Probable angina Atenolol Fasting
|
| Mrs Felicity H Age 52 years Clinical Data: Hypercholesterolaemia Brother died MI Heart Failure
|
| Mr John M Age 62 years Clinical Data: C.A.B.G.
|
A cholesterol protocol
Secondary prevention --> Total cholesterol below 5 mmol/l (proven CHD) (ignore other lipoproteins)
Primary Prevention (risk >30%)--> Total cholesterol to 5 mmol/l or reduce by 30% (which greater)
- USE STATINS OR
- LDH cholesterol to <3 mmol/l or reduce by 30% (which greater)
- OR Total cholesterol:HDL ratio (use Sheffield table)